Therapeutic challenges in Esptein-Barr Virus Cancers
Epstein-Barr virus (EBV) is aetiologically linked to at least seven distinct types of human cancers. With all the EBV-associated tumours collectively imposing a dramatic global health burden estimated to reach 200,000 new cases annually….
This joint laboratory will focus on the developing of dual-modality theranostic techniques (Optical and magnetic resonance imaging - MRI) for inhibition of EBV-associated cancers.
This is intro …..
This proposed joint laboratory will focus on the developing of dual-modality theranostic techniques (Optical and magnetic resonance imaging - MRI) for inhibition of EBV-associated cancers. Theranostics is a contemporary personalized approach that combines the diagnostic agents and targeted therapeutics that specifically permit the diagnostic disease of individuals. Principle scientists from HK have recently achieve a monumental breakthrough in designing EBNA1-responsive bioprobe to interfere with the growth of EBV-associated tumours at a highly effective dosage. We aim to develop specific dual-mode probes for the in vivo MRI and optical imaging. Targeted molecular imaging agent for clinical MRI and optical imaging of EBV-associated malignancies is currently unavailable. This will be achieved through the introduction of various dimerization-specific peptides to the lanthanide for optimization of the target specificity towards EBNA1. CAS scientists in Changchun has a lanthanide probe library, so we can provide the new theranostic agents for EBV associated cancer through this joint project and help to end the EBV associated cancer…..
-
Original project funded for three years from 2018
Key topics
- one
- two
- three
Directors
Ka-Leung Wong
Hong Kong Baptist University
Jun Lin
Professor (test)
Other projects
AKP Test Project
Original project funded for three years from 2024
hello world
Original project funded for three years from 2023
Stay in the loop!
Subscribe to keep up with the latest from Croucher Foundation.